Annual or Biennial Multicancer Early Detection Screening Improves Patient Outcomes

1. Multicancer early detection screening using a single blood sample may improve patient outcomes.

2. A modeling study evaluated potential screening intervals for new multicancer early detection screening tests.

3. Both annual and biennial screening intervals have the potential to avert deaths associated with late-stage cancers, according to results.

4. Screening at different intervals impacts cancer stage at diagnosis and mortality.

5. Annual screening led to more diagnoses within 5 years for patients with fast tumor growth.

6. Biennial screening showed a higher positive predictive value compared with annual screening.

7. The study authors concluded that the optimal choice of screening interval depends on real-world cancer survival assessments and the costs of confirmatory testing.

Source: BMJ Open